Cargando…
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen co...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028008/ https://www.ncbi.nlm.nih.gov/pubmed/35457318 http://dx.doi.org/10.3390/ijerph19084447 |
_version_ | 1784691510250307584 |
---|---|
author | Worakunphanich, Wiwan Youngkong, Sitaporn Suwankesawong, Wimon Anderson, Claire Thavorncharoensap, Montarat |
author_facet | Worakunphanich, Wiwan Youngkong, Sitaporn Suwankesawong, Wimon Anderson, Claire Thavorncharoensap, Montarat |
author_sort | Worakunphanich, Wiwan |
collection | PubMed |
description | Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen countries (eight Western countries and seven Asian countries) were purposively selected. A questionnaire survey was distributed to national pharmacovigilance authorities in those countries. Nine countries (five Western countries and four Asian countries) returned the questionnaire. A review of the websites of national pharmacovigilance centres was conducted. The proportion of patient reports in the selected Western countries ranged from 57.83% to 14.37%, while it was accounted for less than 1% in the selected Asian countries. Currently, patients in all nine countries can report adverse drug reactions online via a website. The number of clicks from the national pharmacovigilance website to reach the online reporting form range from one to five clicks. Countries with higher patient reporting rates seemed to share the following characteristics; provision of feedback, engagement with patient organizations, and implementation of several activities to raise the awareness of the general public on the importance of pharmacovigilance. To increase the number of patient reports, the strengths of each country’s system should be adopted. |
format | Online Article Text |
id | pubmed-9028008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90280082022-04-23 Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries Worakunphanich, Wiwan Youngkong, Sitaporn Suwankesawong, Wimon Anderson, Claire Thavorncharoensap, Montarat Int J Environ Res Public Health Article Patients are recognized as important players in the pharmacovigilance system. This study aims to describe and compare the characteristics of patient reporting systems, reporting forms, awareness raising-activities, and the statistics related to patient reporting in the selected countries. Fifteen countries (eight Western countries and seven Asian countries) were purposively selected. A questionnaire survey was distributed to national pharmacovigilance authorities in those countries. Nine countries (five Western countries and four Asian countries) returned the questionnaire. A review of the websites of national pharmacovigilance centres was conducted. The proportion of patient reports in the selected Western countries ranged from 57.83% to 14.37%, while it was accounted for less than 1% in the selected Asian countries. Currently, patients in all nine countries can report adverse drug reactions online via a website. The number of clicks from the national pharmacovigilance website to reach the online reporting form range from one to five clicks. Countries with higher patient reporting rates seemed to share the following characteristics; provision of feedback, engagement with patient organizations, and implementation of several activities to raise the awareness of the general public on the importance of pharmacovigilance. To increase the number of patient reports, the strengths of each country’s system should be adopted. MDPI 2022-04-07 /pmc/articles/PMC9028008/ /pubmed/35457318 http://dx.doi.org/10.3390/ijerph19084447 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Worakunphanich, Wiwan Youngkong, Sitaporn Suwankesawong, Wimon Anderson, Claire Thavorncharoensap, Montarat Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title | Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title_full | Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title_fullStr | Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title_full_unstemmed | Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title_short | Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries |
title_sort | comparison of patient adverse drug reaction reporting systems in nine selected countries |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028008/ https://www.ncbi.nlm.nih.gov/pubmed/35457318 http://dx.doi.org/10.3390/ijerph19084447 |
work_keys_str_mv | AT worakunphanichwiwan comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries AT youngkongsitaporn comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries AT suwankesawongwimon comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries AT andersonclaire comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries AT thavorncharoensapmontarat comparisonofpatientadversedrugreactionreportingsystemsinnineselectedcountries |